Toxicity and Outcome Results of a Class Solution With Moderately Hypofractionated Radiotherapy in Inoperable Stage III Non–Small Cell Lung Cancer Using Helical Tomotherapy-Reference-Cited by-同舟云学术

Toxicity and Outcome Results of a Class Solution With Moderately Hypofractionated Radiotherapy in Inoperable Stage III Non–Small Cell Lung Cancer Using Helical Tomotherapy

Published:2010-08 Issue:5 Volume:77 Page:1352-1359
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Bral Samuel,Duchateau Michaël,Versmessen Harijati,Engels Benedikt,Tournel Koen,Vinh-Hung Vincent,De Ridder Mark,Schallier Denis,Storme Guy

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

2. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003;Pfister;J Clin Oncol,2004

3. Radiotherapy alone vs. combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients;Le;J Natl Cancer Inst,1991

4. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group;Perez;Cancer,1980

5. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study;Kong;Int J Radiat Oncol Biol Phys,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity;Cancer Treatment Reviews;2024-03

3. Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy;Biomedical Physics & Engineering Express;2022-03-04

4. Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy for Lung Cancer;Medical Radiology;2022

5. Implementation of automatic plan optimization in Italy: Status and perspectives;Physica Medica;2021-12